Abstract
The coronavirus (COVID-19) is a highly infectious disease that emerged in the late December 2019 in Wuhan, China, and it has caused a worldwide outbreak, which represents a major threat to global health. It is important to design prediction research and control strategies to crush its exploding. In this study, a hybrid intelligent model is proposed to simulate the spreading dynamics of COVID-19. First, considering the control measures, such as government investment, media publicity, medical treatment and law enforcement. The infection rates are optimized by genetic algorithm (GA), then a modified susceptible-infected-quarantined-recovered (SIQR) model is proposed, then the long short-term memory (LSTM) is imbedded into the SIQR model to design the hybrid intelligent model to further optimize other parameters of the system model to obtain the optimal predictive model and control measures. This study provide a reliable model to predict cases of infection and death, and reasonable suggestion to control COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
As this study is a systematic review and meta-analysis, no IRB approval is required All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data, models, and code generated or used during the study appear in the submitted article.
